| Literature DB >> 29109027 |
Susmita Bose1, Samuel Ford Robertson2, Amit Bandyopadhyay2.
Abstract
The demand for synthetic biomaterials in medical devices, pharmaceutical products and, tissue replacement applications are growing steadily due to aging population worldwide. The use for patient matched devices is also increasing due to availability and integration of new technologies. Applications of additive manufacturing (AM) or 3D printing (3DP) in biomaterials have also increased significantly over the past decade towards traditional as well as innovative next generation Class I, II and III devices. In this review, we have focused our attention towards the use of AM in surface modified biomaterials to enhance their in vitro and in vivo performances. Specifically, we have discussed the use of AM to deliberately modify the surfaces of different classes of biomaterials with spatial specificity in a single manufacturing process as well as commented on the future outlook towards surface modification using AM. STATEMENT OF SIGNIFICANCE: It is widely understood that the success of implanted medical devices depends largely on favorable material-tissue interactions. Additive manufacturing has gained traction as a viable and unique approach to engineered biomaterials, for both bulk and surface properties that improve implant outcomes. This review explores how additive manufacturing techniques have been and can be used to augment the surfaces of biomedical devices for direct clinical applications.Entities:
Keywords: 3D printing; Additive manufacturing; Biomaterials; Bioprinting; Drug delivery; Surface modification
Mesh:
Substances:
Year: 2017 PMID: 29109027 PMCID: PMC5785782 DOI: 10.1016/j.actbio.2017.11.003
Source DB: PubMed Journal: Acta Biomater ISSN: 1742-7061 Impact factor: 8.947